DiscoverX's Acquisition

DiscoverX was acquired by Eurofins Scientific on July 31, 2017.

DiscoverX has developed the use of I²-galactosidase enzyme fragment complementation (EFC) in HitHunter biochemical and PathHunter cell based assays for discovery research. In addition to the EFC plat…

Articles about DiscoverX's Acquisition: